AGILE THERAPEUTICS INC Quarterly Interest Expense in USD from Q2 2013 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Agile Therapeutics Inc quarterly/annual Interest Expense history and growth rate from Q2 2013 to Q1 2024.
  • Agile Therapeutics Inc Interest Expense for the quarter ending March 31, 2024 was $185K, a 54% decline year-over-year.
  • Agile Therapeutics Inc Interest Expense for the twelve months ending March 31, 2024 was $1.2M, a 54.8% decline year-over-year.
  • Agile Therapeutics Inc annual Interest Expense for 2023 was $1.42M, a 54.7% decline from 2022.
  • Agile Therapeutics Inc annual Interest Expense for 2022 was $3.13M, a 20% decline from 2021.
  • Agile Therapeutics Inc annual Interest Expense for 2021 was $3.91M, a 25.9% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $1.2M $185K -$217K -54% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $1.42M $304K -$128K -29.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 $1.55M $341K -$663K -66% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $2.21M $372K -$451K -54.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 $2.66M $402K -$470K -53.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $3.13M $432K -$568K -56.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 $3.7M $1M +$5K +0.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $3.69M $823K -$170K -17.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $3.86M $872K -$50K -5.42% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $3.91M $1M +$96K +10.6% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-28
Q3 2021 $3.82M $999K +$94K +10.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 $3.72M $993K +$91K +10.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $3.63M $922K +$524K +132% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $3.11M $904K Oct 1, 2020 Dec 31, 2020 10-K 2023-03-23
Q3 2020 $905K Jul 1, 2020 Sep 30, 2020 10-Q/A 2021-12-30
Q2 2020 $902K Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-26
Q1 2020 $398K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2018 $1.12M $160K -$249K -60.9% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 $1.37M $268K -$191K -41.6% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-28
Q2 2018 $1.56M $320K -$184K -36.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 $1.74M $368K -$178K -32.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-03
Q4 2017 $1.92M $409K -$157K -27.7% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-20
Q3 2017 $2.08M $459K -$325K -41.5% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-02
Q2 2017 $2.4M $504K -$44K -8.03% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-03
Q1 2017 $2.44M $546K -$2K -0.37% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-07
Q4 2016 $2.45M $566K +$12K +2.17% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-12
Q3 2016 $2.43M $784K +$233K +42.3% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-06
Q2 2016 $2.2M $548K +$1K +0.18% Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-28
Q1 2016 $2.2M $548K +$123K +28.9% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-08
Q4 2015 $2.08M $554K +$162K +41.2% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-12
Q3 2015 $1.92M $551K +$159K +40.6% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 $1.76M $547K +$144K +35.6% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 $1.61M $425K +$46.8K +12.4% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 $1.57M $392K Oct 1, 2014 Dec 31, 2014 10-K 2017-03-15
Q3 2014 $392K +$13.8K +3.64% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 $403K +$25.3K +6.68% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 $378K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-12
Q3 2013 $378K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 $378K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.